Timothy Schmid - 20 Feb 2026 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, MedTech
Signature
/s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid
Issuer symbol
JNJ
Transactions as of
20 Feb 2026
Net transactions value
-$324,763
Form type
4
Filing time
23 Feb 2026, 17:20:21 UTC
Previous filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schmid Timothy EVP, WW Chair, MedTech ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK /s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid 23 Feb 2026 0001998491

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Sale $324,763 -1,322 -4.9% $245.66 25,447 20 Feb 2026 Direct
holding JNJ Common Stock 46 20 Feb 2026 By ESOP F1
holding JNJ Common Stock 745 20 Feb 2026 By 401k F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
F2 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).